Genomma Lab Internacional, S.A.B. de C.V. Stock Goes Ex-Dividend In Just Four Days - Simply Wall St
| LABB Stock | MXN 25.43 0.76 2.90% |
Slightly above 61% of Genomma Lab's investor base is looking to short. The analysis of current outlook of investing in Genomma Lab Internacional suggests that many traders are alarmed regarding Genomma Lab's prospects. Genomma Lab's investing sentiment can be driven by a variety of factors including economic data, Genomma Lab's earnings reports, geopolitical events, and overall market trends.
Genomma |
Genomma Lab Internacional, S.A.B. de C.V. Stock Goes Ex-Dividend In Just Four Days Simply Wall St
Read at news.google.com
 |
Genomma Lab Fundamental Analysis
We analyze Genomma Lab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genomma Lab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genomma Lab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Genomma Lab is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Genomma Lab Internacional Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genomma Lab stock to make a market-neutral strategy. Peer analysis of Genomma Lab could also be used in its relative valuation, which is a method of valuing Genomma Lab by comparing valuation metrics with similar companies.
Peers
Genomma Lab Related Equities
| ALFAA | Alfa SAB | 0.47 | ||||
| GRUMAB | Gruma SAB | 0.04 | ||||
| GFNORTEO | Grupo Financiero | 1.33 | ||||
| GMEXICOB | Grupo Mxico | 1.34 | ||||
| KIMBERA | Kimberly Clark | 2.05 |
Additional Tools for Genomma Stock Analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.